BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會


Jaime E. Hernandez

Session 5 – Pandemic Control after Vaccination (A)

Date:22 July (Thursday)
Time:  09:00 – 10:30 (GMT+8)

Jaime E. Hernandez, MD, FACP, FIDSA

Executive Medical Director
Syneos Health


Jaime is an Executive Medical Director and Therapeutic Area Medical Lead for Infectious Disease and Vaccines at Syneos Health.
He has broad experience in academic medicine and the pharmaceutical industry, having held leadership positions at GlaxoSmithKline, BioCryst Pharmaceuticals and Syneos Health’s legacy companies, inVentiv Health and INC Research.  Jaime has more than 25 years of experience in drug and vaccine development and conducted research during the 2009 H1N1 influenza A pandemic and during the Ebola and Zika epidemics.  He is currently the medical lead of the Syneos Health COVID-19 Trial Accelerator Team. Jaime is passionate about finding the most expeditious pathway for prophylactic and therapeutic interventions for serious infectious diseases.  He is the author of multiple peer-reviewed manuscripts, abstracts and posters, and has spoken at conferences presenting results of clinical trials advancing antibacterial, antiviral, other antimicrobials and vaccine research.

Speech title & Synopsis

Accelerating Drug and Vaccine Development During Outbreaks